PRAVATO, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 19
NA - Nord America 14
AS - Asia 2
Totale 35
Nazione #
US - Stati Uniti d'America 14
FR - Francia 10
IT - Italia 7
DE - Germania 2
AE - Emirati Arabi Uniti 1
JP - Giappone 1
Totale 35
Città #
Padova 5
Ashburn 3
Paris 2
San Diego 2
Seattle 2
Boardman 1
Brendola 1
Buffalo 1
Cambridge 1
Frankfurt am Main 1
San Francisco 1
Umeda 1
Verona 1
Totale 22
Nome #
Lights and Shade of Next-Generation Pi3k Inhibitors in Chronic Lymphocytic Leukemia, file e14fb26f-c351-3de1-e053-1705fe0ac030 18
Continous Treatment with Ibrutinib in 100 Untreated Patients with TP53 Disrupted Chronic Lymphocytic Leukemia. A Real‐Life Campus CLL Study, file 1d074405-2d70-4d33-a979-caf9a5b10ef5 5
The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia, file 0b3369ba-1329-4135-9e52-6b1c523f2fb4 4
BCR kinase inhibitors, idelalisib and ibrutinib, are active and effective in Richter syndrome, file d7e4eb92-287a-4ae3-b665-be3507ac63fa 4
Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia, file e14fb270-0143-3de1-e053-1705fe0ac030 3
Ibrutinib in relapsed hairy cell leukemia variant: a case report and review of the literature, file e14fb26f-dde8-3de1-e053-1705fe0ac030 1
Totale 35
Categoria #
all - tutte 370
article - articoli 370
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 740


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226 0 0 0 0 0 0 0 0 0 5 1 0
2022/202319 0 2 1 2 2 0 0 0 0 2 10 0
2023/202410 0 0 0 0 0 4 2 1 3 0 0 0
Totale 35